Acute Leukemia of Ambiguous Lineage - 21 Studies Found Recruiting : Filgrastim, Cladribine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes : Acute Biphenotypic Leukemia de Novo Myelodysplastic Syndrome : 2014-01-22 : Drug: Cladribine Given IV Recruiting : Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematological Cancer Who Are Undergoing Umbilical Cord Blood Transplant : Acute Biphenotypic Leukemia Adult Acute Lymphoblastic Leukemia : 2008-11-21 : Drug: Cyclosporine Given IV or Recruiting : Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematologic Disease : Acute Biphenotypic Leukemia Acute Myeloid Leukemia Arising From : 2008-07-19 : Drug: Cyclophosphamide Given I Suspended : Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer : Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Aggres : 2008-07-25 : Procedure: Allogeneic Hematopoietic Stem Cell Transplantation Recruiting : HLA-Mismatched Unrelated Donor Bone Marrow Transplantation With Post-Transplantation Cyclophosphamide : Myelodysplastic Syndrome (MDS) Chronic Lymphocytic Leukemia (CLL) Drug: Fludarabine Completed : AT9283 in Treating Young Patients With Relapsed or Refractory Acute Leukemia : Leukemia : 2011-09-08 : Drug: multikinase inhibitor AT9283 Other: Completed : Busulfan Plus Clofarabine Followed by Allogeneic Hematopoietic Stem Cell Transplantation : Leukemia Lymphoma Allogeneic Haematopoietic Stem Cell Tran : 2009-10-02 : Drug: Busulfan Test Dose 32 mg Not yet recruiting : Phase II Study of Fludarabine, Cytarabine (ARA-C) and Erwinase IV in Patients With Relapsed or Refractory Hematologic Malignancies : Hematologic Malignancy : 2016-03-16 : Drug: Fludarabine Recruiting : Cladribine Plus Idarubicin Plus Cytarabine (ARAC) in Patients With Acute Myeloid Leukemia (AML), High Risk Myelodysplastic Syndrome (HR MDS) or Myeloid Blast Phase of Chronic Myeloid Leukemia (CML) : Leukemia : 2014-04-14 : Drug: Cladribine RECRUITING : Venetoclax Combined With Azactidine in the Treatment of ALAL : : 2024-11-21 : Venetoclax orally once daily (100 mg d1, 200 mg d2, 400 mg d3-28); <<< Previous | Next >>>
